Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease.
Saved in:
| Title: | Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease. |
|---|---|
| Authors: | Broens B; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands., van der Laken CJ; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Simons IA; Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Dekker T; Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Duitman JW; Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Voskuyl AE; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands. ae.voskuyl@amsterdamumc.nl. |
| Source: | Arthritis research & therapy [Arthritis Res Ther] 2025 Sep 29; Vol. 27 (1), pp. 184. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
